Department: Market Access; Late Phase Clinical Operations and Real World EvidenceResponsible for - Conception, planning, conduct and evaluation of late-phase non-interventional studies (registries and post-authorization safety studies in anticoagulation)- Generation, review and approval of trial related documents - Generation and review of trial and disease related medical material and communication incl. publications - Training of internal CRAs regarding study requirements - International project- and interface management in a matrix environment ensuring all deliverables meet the quality, timeline, resource and budget commitments - Daily management and supervision of CROs and other 3rd party service providers- Study and disease area related interactions with KOLs and HCPs in Steering Committees, Advisory Boards, Data Safety Boards and Investigator Meetings - Tight collaboration with Medical Affairs assuring study designs are in accordance with the global medical strategy as well as with HEOR/PRA ensuring optimal reflection of pricing and reimbursement needs in all relevant studies

In charge of- Non-Interventional Studies and Investigator Initiated Trials- Advisory boards, symposia and investigator meetings- Scientific and medical care of products and indication- Analysis and presentation of medical information- Requests from physicians, pharmacists and patients

In charge of the BLOPRESS and Non-Interventional Studies

Selected responsibilities:- Project manager international studies on pacemaker , ICDand cardiac resynchronisation therapy- Project leader ‚Scientific Marketing / Landmark-TrialAnalysis’